CELL INTELLIGENCE · 肿瘤细胞治疗研究

CRISPR 激活筛选鉴定 MUC-21 为抵抗 NK 和 T 细胞介导细胞毒性的关键分子

A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity.

这些发现表明，表面 MUC21 是一种强效免疫抑制配体，可保护癌细胞免受 NK 和 CD8⁺ T 细胞的攻击。

ROBO1 CAR-NK92 细胞中 Cbl-b 敲除增强其抗肿瘤疗效

Ablation of Cbl-b in ROBO1 CAR-NK92 Cells Enhances Their Antitumor Efficacy.

三阴性乳腺癌免疫治疗的进展与展望

Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.

非小细胞肺癌的靶向治疗及 AI 干预在癌症治疗中的潜在作用

Targeted therapies in non-small cell lung cancer and the potential role of AI interventions in cancer treatment.